ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,659,577 | +788.5% | 28,584 | +723.7% | 0.01% | +1100.0% |
| Q2 2023 | $186,790 | -32.2% | 3,470 | -50.0% | 0.00% | -50.0% |
| Q1 2023 | $275,458 | -2.0% | 6,935 | -20.8% | 0.00% | 0.0% |
| Q3 2022 | $281,000 | -76.4% | 8,751 | -66.2% | 0.00% | -81.8% |
| Q4 2021 | $1,192,000 | +195.0% | 25,869 | +107.0% | 0.01% | +57.1% |
| Q2 2020 | $404,000 | +7.4% | 12,499 | +104.7% | 0.01% | 0.0% |
| Q4 2019 | $376,000 | -34.0% | 6,105 | -22.0% | 0.01% | -36.4% |
| Q3 2019 | $570,000 | +62.4% | 7,824 | +0.2% | 0.01% | -35.3% |
| Q4 2018 | $351,000 | -66.6% | 7,805 | -56.7% | 0.02% | -72.1% |
| Q1 2018 | $1,050,000 | +390.7% | 18,027 | +280.0% | 0.06% | +369.2% |
| Q4 2015 | $214,000 | -79.8% | 4,744 | -72.3% | 0.01% | -75.0% |
| Q2 2015 | $1,061,000 | +415.0% | 17,100 | +368.4% | 0.05% | +372.7% |
| Q4 2014 | $206,000 | – | 3,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |